NASDAQ:LITS Lite Strategy (LITS) Stock Price, News & Analysis $0.92 +0.01 (+1.43%) Closing price 04:00 PM EasternExtended Trading$0.93 +0.01 (+1.15%) As of 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Lite Strategy Stock (NASDAQ:LITS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Lite Strategy alerts:Sign Up Key Stats Today's Range$0.89▼$0.9750-Day Range$0.74▼$1.2552-Week Range$0.69▼$9.00Volume401,799 shsAverage Volume495,799 shsMarket Capitalization$31.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. MEI Pharma, Inc. has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. Read More Lite Strategy Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreLITS MarketRank™: Lite Strategy scored higher than 41% of companies evaluated by MarketBeat, and ranked 66th out of 97 stocks in the manufacturing sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingLite Strategy has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageLite Strategy has only been the subject of 1 research reports in the past 90 days.Read more about Lite Strategy's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Lite Strategy is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Lite Strategy is -0.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLite Strategy has a P/B Ratio of 0.19. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.29% of the float of Lite Strategy has been sold short.Short Interest Ratio / Days to CoverLite Strategy has a short interest ratio ("days to cover") of 0.18, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Lite Strategy has recently decreased by 36.81%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLite Strategy does not currently pay a dividend.Dividend GrowthLite Strategy does not have a long track record of dividend growth. News and Social Media4.0 / 5News Sentiment1.33 News SentimentLite Strategy has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Manufacturing companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Lite Strategy this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Lite Strategy to their MarketBeat watchlist in the last 30 days. Company Ownership3.5 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $21,500.00 in company stock, which represents 0.0685% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Lite Strategy insiders have bought more of their company's stock than they have sold. Specifically, they have bought $21,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders1.60% of the stock of Lite Strategy is held by insiders.Percentage Held by Institutions52.38% of the stock of Lite Strategy is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Lite Strategy's insider trading history. Receive LITS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lite Strategy and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LITS Stock News HeadlinesLite Strategy (NASDAQ:LITS) Director Acquires 25,000 Shares of StockJune 26, 2026 | insidertrades.comCan LitVM Bring Smart Contracts to Litecoin Without Changing Its Identity?June 23, 2026 | finance.yahoo.comSolar is dead. Here’s what replaces it.Starting July 4th, every new solar and wind project in America loses its federal tax credits. But one zero-carbon energy source retains full government backing for eight more years - and it runs around the clock without batteries. Investment in this sector has surged 100x in seven years. The Pentagon named it a top energy priority, California mandated it, and Google, Meta, and Berkshire Hathaway are already under contract. One company controls the entire chain from the ground to the grid.June 30 at 1:00 AM | Behind the Markets (Ad)Lite Strategy, Inc. to Join Litecoin Foundation Summit Panel on Litecoin’s Institutional OpportunityJune 19, 2026 | quiverquant.comQLite Strategy to Attend Panel at Litecoin Foundation Summit in AmsterdamJune 19, 2026 | globenewswire.comExclusive: Lite Strategy leads $1m investment in Litecoin Layer 2 platform LitVMJune 19, 2026 | finance.yahoo.comLite Strategy Leads Strategic Investment in LitVMJune 18, 2026 | markets.businessinsider.comLite Strategy, Inc. Common Stock (LITS) SEC FilingsMay 20, 2026 | nasdaq.comSee More Headlines LITS Stock Analysis - Frequently Asked Questions How have LITS shares performed this year? Lite Strategy's stock was trading at $1.32 on January 1st, 2026. Since then, LITS shares have decreased by 30.1% and is now trading at $0.9224. How were Lite Strategy's earnings last quarter? Lite Strategy, Inc. (NASDAQ:LITS) released its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.66) EPS for the quarter. Is Lite Strategy doing a stock buyback? Lite Strategy's board approved a stock buyback program on Wednesday, October 29th 2025, which allows the company to repurchase $25,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 36.3% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its shares are undervalued. How do I buy shares of Lite Strategy? Shares of LITS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/13/2026Today6/30/2026Fiscal Year End6/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (9m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 LITS's financial health is in the Red zone, according to TradeSmith. LITS has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Pharmaceutical Preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:LITS CIK1262104 WebN/A Phone(858) 369-7100Fax302-655-5049Employees100Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$15.94 million Net MarginsN/A Pretax MarginN/A Return on Equity-90.81% Return on Assets-89.33% Debt Debt-to-Equity RatioN/A Current Ratio11.53 Quick Ratio11.53 Sales & Book Value Annual Sales$65.30 million Price / Sales0.48 Cash Flow$6.15 per share Price / Cash Flow0.15 Book Value$4.96 per share Price / Book0.19Miscellaneous Outstanding Shares34,030,000Free Float33,481,000Market Cap$31.39 million OptionableN/A Beta0.21 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:LITS) was last updated on 6/30/2026 by MarketBeat.com Staff. From Our PartnersPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored[Free Report] The 11-Hour Options Guide for Beginners - trade and ticker includedTired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredThe startup growing 23 times faster than NvidiaAn official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes ...Brownstone Research | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredForget the million-dollar nest egg — you only need THIS muchNearly 2 in 3 Americans fear running out of money more than death - and chasing a $1.5 million nest egg isn't ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lite Strategy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lite Strategy With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LITS Stock Alerts